Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalaka Joshi

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 31, 2025
Cumulative Risk of Cosmetic Worsening Following Ultrahypofractionated Whole Breast Radiation Therapy With Simultaneous Integrated Boost: The Largest Real-World DataTabassum Wadasadawala, Naseera Syeda, Shraddha Kenekar, et al.
Cancer Research Communications|February 5, 2024
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast CancerNilesh Gardi, Rohan Chaubal, Pallavi Parab, et al.
Indian Journal of Surgical Oncology|January 8, 2024
Synchronous and Metachronous Breast and Ovarian Cancers: Experience from a Single Tertiary Care Cancer Centre in IndiaShalaka Joshi, Sridevi Murali-Nanavati, T S Shylasree, et al.
JAMA Network Open|October 2, 2023
Effectiveness of a Decision Aid Plus Standard Care in Surgical Management Among Patients With Early Breast Cancer: A Randomized Clinical TrialShalaka Joshi, Lakshmi Ramarajan, Naresh Ramarajan, et al.
Indian Journal of Surgical Oncology|May 8, 2025
Prevalence of Distant Metastases in High-Risk Operable Breast Cancer (HROBC) pT1-2 N2a or Higher at DiagnosisVani Parmar, Naveena Kumar An, Nita S Nair, et al.
Scientific Reports|August 1, 2025
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancerKripa Bajaj, Sushmita Rath, Deep Vora, et al.
Journal of Surgical Oncology|November 3, 2021
Surgical Site Infections in patients undergoing major oncological surgery during the COVID-19 paNdemic (SCION): A propensity-matched analysisGouri Pantvaidya, Shalaka Joshi, Prakash Nayak, et al.
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
Breast (Edinburgh, Scotland)|February 28, 2021
Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, IndiaJyoti Bajpai, Vijay Simha, T S Shylasree, et al.
Scientific Reports|November 4, 2025
Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patientsKhusbhoo A Gandhi, Rohan Chaubal, Elizabeth Talker, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|May 31, 2025
Cumulative Risk of Cosmetic Worsening Following Ultrahypofractionated Whole Breast Radiation Therapy With Simultaneous Integrated Boost: The Largest Real-World DataTabassum Wadasadawala, Naseera Syeda, Shraddha Kenekar, et al.
Cancer Research Communications|February 5, 2024
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast CancerNilesh Gardi, Rohan Chaubal, Pallavi Parab, et al.
Indian Journal of Surgical Oncology|January 8, 2024
Synchronous and Metachronous Breast and Ovarian Cancers: Experience from a Single Tertiary Care Cancer Centre in IndiaShalaka Joshi, Sridevi Murali-Nanavati, T S Shylasree, et al.
JAMA Network Open|October 2, 2023
Effectiveness of a Decision Aid Plus Standard Care in Surgical Management Among Patients With Early Breast Cancer: A Randomized Clinical TrialShalaka Joshi, Lakshmi Ramarajan, Naresh Ramarajan, et al.
Indian Journal of Surgical Oncology|May 8, 2025
Prevalence of Distant Metastases in High-Risk Operable Breast Cancer (HROBC) pT1-2 N2a or Higher at DiagnosisVani Parmar, Naveena Kumar An, Nita S Nair, et al.
Scientific Reports|August 1, 2025
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancerKripa Bajaj, Sushmita Rath, Deep Vora, et al.
Journal of Surgical Oncology|November 3, 2021
Surgical Site Infections in patients undergoing major oncological surgery during the COVID-19 paNdemic (SCION): A propensity-matched analysisGouri Pantvaidya, Shalaka Joshi, Prakash Nayak, et al.
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
Breast (Edinburgh, Scotland)|February 28, 2021
Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, IndiaJyoti Bajpai, Vijay Simha, T S Shylasree, et al.
Scientific Reports|November 4, 2025
Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patientsKhusbhoo A Gandhi, Rohan Chaubal, Elizabeth Talker, et al.
Pageof 6